Anti-diabetes therapy: Safety considerations for patients with impaired kidney function

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


The presence of type 2 diabetes mellitus (T2DM) is a common risk factor for the development of chronic kidney disease, but appropriate glycemic control can slow the progression of kidney dysfunction in patients with T2DM. The kidney plays a role in insulin resistance and gluconeogenesis, therefore, impaired kidney function alters glucose dynamics compared with normal kidney function, thus affecting antihyperglycemic treatment strategies. Glycemic management is further complicated by reduced drug clearance and a greater risk of hypoglycemia with use of certain medications, notably the sulfonylureas. Of the classes of antihyperglycemic drugs discussed in this review, caution is advised when using some classes in patients with T2DM and kidney disease.

Original languageEnglish
Pages (from-to)161-171
Number of pages11
JournalPostgraduate medicine
Issue number3
StatePublished - Jan 1 2014


  • Chronic kidney disease
  • Clinical management
  • Incretin therapy
  • Type 2 diabetes mellitus


Dive into the research topics of 'Anti-diabetes therapy: Safety considerations for patients with impaired kidney function'. Together they form a unique fingerprint.

Cite this